Get started
Enlivex Ltd.Enlivex Ltd.Enlivex Ltd.

Enlivex Ltd.

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪177.87 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
0.0294
Basic EPS (TTM)
27.0375 USD
Net income (FY)
‪1.24 B‬ USD
Revenue (FY)
0.00 USD
Shares float
‪31.45 M‬
Beta (1Y)
−0.56

Employees


Employees (FY)
34
Change (1Y)
−2 −5.56%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪36.34 M‬ USD

About Enlivex Ltd.


Sector
Health Technology
Industry
Biotechnology
CEO
Oren Hershkovitz
Website
enlivex.com
Headquarters
Ness Ziona
Founded
2012
IPO date
Jul 30, 2014
Identifiers
2
ISIN IL0011319527
CFI code
ESVUFR
Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.

Check out other big names from the same industry as ENLV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IZRL
ARK Israel Innovative Technology ETF
Weight 0.91%
Market value ‪1.28 M‬
TCH.F85
Tachlit SAL (40) TA Growth
Weight 2.45%
Market value ‪588.70 K‬
KSM.F75
KSM ETF (4A) TA Global-BlueTech Units
Weight 2.41%
Market value ‪342.22 K‬
MTF.F18
MTF SAL (4A) TA Tech - Elite IL
Weight 0.67%
Market value ‪162.99 K‬
KSM.F21
KSM ETF (4A) TA-Growth
Weight 2.45%
Market value ‪140.85 K‬
QQQS
Invesco NASDAQ Future Gen 200 ETF
Weight 0.28%
Market value ‪46.61 K‬

Explore more ETFs 

Frequently asked questions


The current price of ENLV is 0.7324 USD — it has decreased by −2.26% in the past 24 hours. Watch Enlivex Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Enlivex Ltd. stocks are traded under the ticker ENLV.
ENLV stock has fallen by −10.68% compared to the previous week, the month change is a −16.29% fall, over the last year Enlivex Ltd. has showed a −27.73% decrease.
We've gathered analysts' opinions on Enlivex Ltd. future price: according to them, ENLV price has a max estimate of 20.00 USD and a min estimate of 20.00 USD. Watch ENLV chart and read a more detailed Enlivex Ltd. stock forecast: see what analysts think of Enlivex Ltd. and suggest that you do with its stocks.
ENLV reached its all-time high on Jul 31, 2014 with the price of 264.0000 USD, and its all-time low was 0.6600 USD and was reached on Dec 31, 2025. View more price dynamics on ENLV chart.
See other stocks reaching their highest and lowest prices.
ENLV stock is 11.14% volatile and has beta coefficient of −0.56. Track Enlivex Ltd. stock price on the chart and check out the list of the most volatile stocks — is Enlivex Ltd. there?
Today Enlivex Ltd. has the market capitalization of ‪177.87 M‬, it has decreased by −11.60% over the last week.
Yes, you can track Enlivex Ltd. financials in yearly and quarterly reports right on TradingView.
Enlivex Ltd. is going to release the next earnings report on May 22, 2026. Keep track of upcoming events with our Earnings Calendar.
Enlivex Ltd. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ENLV net income for the last quarter is ‪1.24 B‬ USD, while the quarter before that showed ‪−2.21 M‬ USD of net income which accounts for 0.00% change. Track more Enlivex Ltd. financial stats to get the full picture.
No, ENLV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 14, 2026, the company has 34 employees. See our rating of the largest employees — is Enlivex Ltd. on this list?
Like other stocks, ENLV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enlivex Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enlivex Ltd. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enlivex Ltd. stock shows the strong sell signal. See more of Enlivex Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.